Nicole Murphy
At a glance: Nicole Murphy is Head Of Pharm Ops And Tech at Biogen (BIIB). Their latest SEC Form 4, filed Feb 17, 2026, reported a purchase of $585. On file: 1 purchase line ($585) and 0 sale lines ($0).
Disclosed holdings: about $4.9M of BIIB stock: 19,611 shares reported on their latest Form 4 (filed Feb 17, 2026), valued at the Nov 20, 2026 close of $249.69. This counts only BIIB shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Head Of Pharm Ops And Tech at Biogen Inc. (BIIB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 17SEC | BIIBBiogen Inc.First buy | Buy | 319,611 held (+0%) | $195.03 | $585 | +28.0% |
- Buy
Head Of Pharm Ops And Tech Nicole Murphy bought $585 of BIIB at $195.03 — first open-market purchase in our records.
Follow Nicole Murphy
Get one email when Nicole Murphy files a new purchase or sale. Free.
At most one email a day about Nicole Murphy, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.